SMMT logo
Summit Therapeutics Inc.(SMMT)
Closing price · checked 8:38 PM ETAbout this dataData status
$9.95▼-0.62 (-5.87%)
Extended:$10.07+0.12 (+1.21%)· 8:38 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Summit Therapeutics Inc. (SMMT)

Net Receivables

$0.00

Quarterly · Period ending: · USD

SMMT logo

SMMT Net Receivables

Latest reported$0.00
SMMT FY Net Receivables ($0.00 → $0.00)
High-resolution chart · PNG

What is net receivables?

Net amount expected from customer receivables.

SMMT net receivables history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Summit Therapeutics Inc. Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)Change
0−100.00%
557,000−34.32%
848,000−86.13%
6,115,000−64.36%
17,159,000+68.44%
10,187,000+3,102.26%
318,119−97.46%
12,506,138—
0—
0—
0—
0−100.00%
717,803+1,307.46%
51,000−89.63%
492,032+57.22%
312,948−25.98%
422,788−72.56%
1,540,999+5.44%
1,461,465+47.04%
993,933+181.79%
352,727—
0—
0—

Frequently asked questions: SMMT net receivables

What is Summit Therapeutics Inc. (SMMT)'s current net receivables?

Summit Therapeutics Inc. (SMMT)'s latest reported net receivables (Quarterly) is $0.00 as of Sep 30, 2026. Net amount expected from customer receivables.

How much historical net receivables data is available for SMMT?

Stock Alarm Pro provides 23 dated annual fiscal periods observations for Summit Therapeutics Inc. (SMMT)'s net receivables, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare SMMT's net receivables to peers or set an alert?

You can open SMMT's net receivables in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SMMT delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.